Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cirrhotic cardiomyopathy.

Soon Koo Baik1, Tamer R Fouad, Samuel S Lee

  • 1Dept of Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea. baiksk@yonsei.ac.kr

Orphanet Journal of Rare Diseases
|March 29, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dendrite initiation and deflection in biaxially stressed solid electrolytes.

Nature·2026
Same author

A Gender-Based Descriptive Analysis of the Canadian Network Undertaking Against Hepatitis C (CANUHC) Cohort From 2015-2023.

Open forum infectious diseases·2026
Same author

Mannose receptor-targeted MSC-derived exosomes as a high-affinity delivery platform for liver sinusoidal endothelial cells.

Drug delivery and translational research·2026
Same author

Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in Lowering the Risk of HCC Development in Patients With CHB.

Journal of gastroenterology and hepatology·2026
Same author

Impact of gastrectomy on the risk of alcohol-associated liver disease in patients with gastric cancer.

Scientific reports·2026
Same author

Preclinical Analysis of Bone Marrow-Derived Stem Cell Therapy Response and Transcriptomic Overlap Analysis in a Severe Alcoholic Hepatitis Mouse Model.

Gut and liver·2026

Cirrhotic cardiomyopathy, a heart condition in cirrhosis patients, presents latent dysfunction worsened by stress. Early diagnosis and supportive care are crucial for managing this condition.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Cirrhotic cardiomyopathy (CC) describes cardiac dysfunction in cirrhosis patients.
  • It involves systolic/diastolic dysfunction, electrophysiological changes, and structural alterations.
  • CC is often latent, manifesting under physiological or pharmacological stress.

Purpose of the Study:

  • To define cirrhotic cardiomyopathy and its clinical features.
  • To explore its pathogenesis and diagnostic approaches.
  • To review current management and prognosis.

Main Methods:

  • Literature review of cirrhotic cardiomyopathy.
  • Analysis of clinical features, diagnostic methods, and pathogenic mechanisms.
  • Evaluation of management strategies and prognosis.

Related Experiment Videos

Main Results:

  • CC features include increased cardiac output, attenuated contractility/relaxation under stress, and prolonged QT intervals.
  • Diastolic dysfunction typically precedes systolic dysfunction.
  • Stresses like liver transplantation or TIPS can unmask latent CC, potentially leading to overt heart failure.

Conclusions:

  • Cirrhotic cardiomyopathy is a significant complication of cirrhosis with multifactorial pathogenesis.
  • Diagnosis requires careful assessment, including stress testing.
  • Management is largely supportive, with potential for reversibility; further research is needed.